New 3'-, 5'-, 5-bromo-2'-deoxyuridine (3 a -g ) and 3'-, 5'-thymidine (4 a -i) analogues with amino acid and peptide residues were synthesized and evaluated for antiviral activity. The influence of long peptide chains, essential amino acids and the effect of this structural modifi cation on the antiviral activity has been also reported.
Introduction
Analogues of 2'-deoxynucleosides modified at the 3'-and/or 5'-position are of a great im por tance for medicinal chemistry and biochemistry as potential anticancer and/or antiviral agents (Uhlmann et al., Holy et al., 1994) . Some of these compounds are rather efficient therapeutic agents for the treatm ent of patients with AIDS, but some of them showed m arked toxic side effects. In attem pts to overcome the problem of rapid elimi nation and decreased permeability of 3'-azido-2', 3'-dideoxythymidine, A Z T through the bloodbrain barrier and to increase its therapeutics effi ciency, Aggarwal et al. (1990) 
studied a variety of
Abbreviations: Z, benzyloxycarbonyl; Boc, N-tert-butoxycarbonyl; TBTU, N -[(l-H -benzotriazol-l-yloxy) (dimethylamino) methylene]-N-methyl-, tetrafluoroborate; DMF, N, N-dimethylformamide; DMAP, 4-dime-thylaminopyridine; D IEA , diizopropylethyl amine; BUdR, 5-bromo-2'-deoxyuridine. HIV, human immunodeficiency virus; HSV-1, herpes simplex virus 1; PsRV, pseudo Rabies virus; M IC50, mini mal 50% inhibitory concentration; CC ID 50, cell culture 50% infections dose; MTC, maximum tolerated concen tration; SI, selectivity index. Reprint requests to Dr. Stankova. Fax: 003597329325. E-mail: ivankast@aix.swu.bg 5'-esters of AZT. They prepared N-substituted piperazine and morpholine esters, and 1,4-dihydrol-methyl-3-[(pyridylcarbonyl) oxy] ester for trans port into neuron tissues (Haines et al., 1987) , ester of retinoic acid which itself inhibits HIV replica tion and selected amino acids to use their specific transport properties. Since bone marrow cells lack amino acid transport system (Vistica, 1980) it has been presumed that such an A ZT derivatives may be less toxic for bone marrow cells. These deriva tives are generally less toxic and they are taken up by cells more easily.
The modification of various biological active compounds with amino acids allows them to be hydrolyzed more quickly under the influence of plasma enzymes, thus leading to their transform a tion as prodrugs. On the other hand these com pounds exhibited poor stability in aqueous solu tion as exemplified with esters of metronidazole (Cho et al., 1985) , acyclovir (Colla et al., 1983; Bundgaard et al., 1991) , ganciclovir , corticosteroids (Kawamura et al., 1971; Jonson et al., 1985) , and paracetam ol Kovach et al., 1981) . One of the solu tion to overcome such problem is the use of ade quately selected spacer groups.
Considering all these facts, we have been inter ested to estimate the role of modification in the 0939-5075/99/0100-0075 $ 06.00 © 1999 Verlag der Zeitschrift für Naturforschung, Tübingen • www.znaturforsch.com • N 3'-and 5'-position with selected amino acid and peptide residues (Stankova et al., 1996; Alargov et al., 1997) . We report here the synthesis and biolog ical (antiviral) evaluation of several amino acid and peptide derivatives of 5-bromo-2'-deoxyuridine and thymidine shown in Fig. 1 .
We have also considered the role of chirality, aromatic, heterocyclic amino acid residues, the ad dition of the long peptide chains formed of glycine to 5-bromo-2'-deoxyuridine and thymidine, and the effect of these structural modifications on anti viral activity.
Results and Discussion
Nucleosides modified with amino acids are not so many, but nucleosides containing peptide resi dues are not known at all. In order to obtain anti metabolites with antiviral activity that have more desirable characteristics than those analogues now known, we synthesized a series of new 3'-, 5'-, 5-brom o-2'-deoxyuridine as well as thymidine ana logues containing amino acid and peptide residues. The a-am ino group of glycine, phenylalanine, ala nine and valine (la, Id, lh , li) was protected by the appropriate groups of urethane type -such as benzyloxycarbonyl (Z) (Bergmann et al., 1932) , and in the case of thiazole containing glycine (1 g) with butoxycarbonyl (Boc) (Pozdnev, 1977) .
To obtain di-and tri-peptides (lb , lc) the m od els was used the two well known m ethods for pep tide bond formation: the active ester m ethod (A n derson et al., 1964), and those of the mixed anhydrides (Zaoral, 1962) . Optically pure N-a-Z-(4-F)-phenylalanine (S', R ) (le , If) we obtained from a suitable protected ester by enzymatic hy drolysis using the alkaline proteinase, subtilisin DY (Tong et al., 1971; Aleksiev et al., 1981) . N-
tert-
butoxycarbonyl-2-aminomethyl-thiazole-4-carboxylic acid (1 g) was synthesized from a corre sponding protected amino acid by the modified Hantsch m ethod according to . The target acylated 3 a -g , 4 a -i compounds were prepared by previous activation in situ of the amino acids or peptides using the reagent TBTU in the presence of 4-dimethylamino-pyridine (DM AP), (Knorr, 1989) at room temperature. Purification of the crude product was achieved by column chromatography which gave a yield of 3,,5'-0-bis-5-brom o-2'-deoxyuridine derivatives of 43-60% , and 3',5'-0-bisthymidine analogues of 70-79% .
It should be noted that our chosen approach yielded the desired products with a higher degree of optical purity and a faster condensation than those currently known.
A nother advantage of the condensation method we have favored is lack of undesirable side pro cesses including racemization.
Biological activity
Initially the new analogues 3 a -g , 4 a -i were evaluated for their antiviral activity towards influ enza virus A / chicken / Germany / 27 / Weybridge (H7N7) (FPV) and pseudorabies virus (Aujeszky, A2 strain) (PsRV) growth in prim ary chick embryo fibroblasts cultures (CEC). Results of the antiviral screening of 5-bromo-2'-deoxyuridine and thymidine derivatives by the agar diffusion plaque -inhibition test are shown in Table I and  Table II .
These data clearly dem onstrate the marked anti -herpes virus potential of these compounds, comparable of that of 5-bromo-2'-deoxyuridine in the case of 3b. Table I . Screening of BU dR derivatives 3 a -g for antivi ral activity by the agar-diffusion plaque inhibition test.
1 0 +++ * All tested com pounds w ere applied at the con cen tra tion o f 5 x 10~3 m. 4>j = diameter of inhibition zone (mm); 4>t = diameter of toxicity zone (mm); E = antiviral effect; BUdR = 5-bromo-2'-deoxyuridine; FPV, influenza virus A (H7N7); PsRV, pseudorabies virus; N. T., not tested. It is im portant to stress that there is no differ ence in activity between the R and S isomers 3e, f and 4e, f.
Analogue of phenylalanine with 5-bromo-2'-deoxyuridine (3d) do not show activity, and ana logue of thymidine (4d) exhibited a borderline ac tivity.
As seen in Table I compound 3b has a strong activity against herpes virus PsRV. This activity was com parable with that of BUdR used as a ref erence antiherpes virus compound. Compounds 3a, 3c, showed a marked but less pronounced ef fect as com pared to 3b. The rest of the compounds was inactive, and neither analogue showed activity against the influenza virus model.
The corresponding derivatives of the normal m etabolite -thymidine -do not show any anti virus activity as seen in Table II. The three compounds 3a, 3b, 3c showed antiher pes activities to HSV-1 in the cytopathic effect (CPE) inhibition test. However, they showed a decrease of the effect selectivity, especially strongly expressed in 3c (Table III) .
In conclusion, these results dem onstrated that among the compounds tested, peptide analogues possessed a marked antiviral activity in com pari son with these of the amino acids. In addition, elongation of the peptide chain enhanced antivi ral activity. 
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HSV-1 = herpes simplex virus 1; MIC30 = minimal 50% inhibitory concentration; MTC = maximum tolerated concentration; SI = selectivity index; BUdR = 5-bromo-2'-deoxyuridine.
The rational synthesis of our compounds was based on the fact that some amino acid esters of nucleosides are known as prodrugs (Perry et al., 1996) . It is possible that the compounds obtained are prodrugs of BUdR (the active antiherpes virus moiety). An implicit proof of this assumption lies in the fact that the activity of these three com pounds (3a, 3b, 3c) does not exceed that of BUdR. F urther systematic research in vivo is needed for additional proof of the above assumption.
Materials and Methods
All reagents were from Fluka AG, Buchs (CH). TLC analysis was performed on aluminum sheets Silica gel 60 F254 (Merck, Germany) using the eluent systems: A-ethyl acetate/n-hexane (6:1 v:v) and B-CHCI3/M eOH (9:1 v:v). Silica gel 60 (230-400 mesh), also a Merck product, was used for flash chromatography. The derivatives were visual ized with UV light (254 nm), charring reagent and/ or ninhydrin.
Melting points were determ ined using a Kofler apparatus. Optical rotations were determ ined with a Perkin -Elm er 241 polarim eter at 20 °C.
NM R spectra were recorded on a Bruker AC -250 -Spektrom eter.
'H NM R chemical shifts are reported in ö ppm relative to DMSO (2.49 ppm) as an internal stan dard, and '3C chemical shifts are reported in ppm relative to M eOH (49.15 ppm) unless specified otherwise. Multiplicities in 'H NMR are reported as (s) singlet, (d) doublet, (dd) doublet of doublets, (t) triplet, (q) quartet, and (m) multiplet. Mass spectrometry: API III triple quadrupole mass spectrom eter equipped with an electrospray ion source at atmospheric pressure (Sciex, Thornhill, Canada); electrospray ionization mass spectra (ESI-MS) were recorded in the positive mode.
Synthesis
G eneral procedure for the synthesis of the pro tected 3', 5'-0-bis-5-bromo-2'-deoxyuridine (3 ag) and 3', 5'-0-bis-thym idine (4 a -i) derivatives.
The compounds l a -i were synthesized accord ing to a known procedure (Bergmann et al., 1932; Pozdnev, 1974; Anderson, 1964; Zaoral, 1962; Tong, 1971; Aleksiev et al., 1981; Videnov et al., 1996) . l a -i (3 mmol), D IE A (3.1 mmol) was added to a solution of TBTU (3 mmol) in DMF (15 ml) (Knorr, 1989) . A fter stirred the mixture was treated with 5-bromo-2'-deoxyuridine or thymi dine (1.5 mmol) along with DM AP (3 mmol). This mixture was stirred at room tem perature for 3 h, and then evaporated to dryness. The residue dis solved in ethyl acetate, washed with 1 0 % N a H C 0 3, water, brine and dried over Na2S 0 4. A f ter evaporation the residue was purified by flash chromatography with ethyl acetate/n-hexane (6/1 v/v) mixtures as eluent. = 17.6, 6.4 Hz; 3.95 (dd, 1H, 3J = 17.6, 6.4 Hz; 4.14 (dd, 1H, 3J = 4.5, 7.7, 12.7 Hz, H 4'), 4.26 (dd, 1H, 3J = 12.0, 5.8 Hz; H 5" ), 4.32 (dd, 1H, 3J = 11.8, 3.9 Hz; H 5'), 2H, 5.22 (m, 1H, H 3'), 6.17 (dd, 1H, 3J = 6.5, 7.8 Hz; H I '), 10H, C6H 5), 7.49 (s, 1H, H6), 7.52 (dd, 1H, 3J = 9.6, 6.5 Hz; NH), 8.35 (dd, 1H, 3J = 6.7, 4 Hz; N H '), 11.32 (br.s, 1H, H3) . 13C NMR: 40.53, 40.64, , 43.31 (C a '-Gly), 64.09 (C-5'), 65.51 (CH2-0 ), 74.49 (C-3'), 81.63 (C-4'), 84.64 (C -l'), 110.15 (C-5), 129.15, 128.61, 127.57 (C6H 5, C-3,4), 136.73, (C6H 5, C -l) 
A ntiviral test
Primary screening for antiviral activity was car ried out using the agar-diffusion plaque-inhibition m ethod with cylinders (Rada et al., 1962; Galabov et al., 1980) . It included testing of compounds against representatives of two taxonomic viral groups, namely orthomyxo and herpes viruses, which represent a few of the most im portant fami lies of human pathogens. The viruses used were FPV and PsRV, respectively. Monolayer cell cul tures of CEC in 90-mm petri dishes were inocu lated (60 min adsorption at 20 °C) with a virus dose giving semiconfluent plaques after incubation at 37 °C (48h with FPV, 72 h with PsRV). Test compounds (0.005 mol/1 solutions in DMSO) were added dropwise within 6-mm glass cylinders fixed in the agar overlay [1% Bactoagar (Difco) in E a gle's MEM (Gibco) medium with heated calf se rum, 1.65 mg/ml sodium bicarbonate and antibiot ics, penicillin 100 IU/ml and streptomycin 100 [Ag/ ml]. A second overlay containing 1.5% (w/v) agar and 0.002% (w/v) neutral red in physiological sa line was added after the incubation. The antiviral effect (E) of a given compound was recorded on the basis of the difference (A4>) between the size of the zone of plaque inhibition (diameter AOj in mm) and zone of cytotoxycity (A<I>t ) (four cylin-
